DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.
about
Selective inhibition of yeast regulons by daunorubicin: a transcriptome-wide analysis.Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy.Complexes of the antitumoral drugs Doxorubicin and Sabarubicin with telomeric G-quadruplex in basket conformation: ground and excited state properties.Affinity of the anthracycline antitumor drugs Doxorubicin and Sabarubicin for human telomeric G-quadruplex structures.Citric acid-γ-cyclodextrin crosslinked oligomers as carriers for doxorubicin delivery.Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosidesCardiotoxicity After Anthracycline Treatment in Survivors of Adult Cancers: Monitoring by USCOM, Echocardiography and Serum Biomarkers.β-Cyclodextrin polymer nanoparticles as carriers for doxorubicin and artemisinin: a spectroscopic and photophysical study.1-Amino-4-hydroxy-9,10-anthraquinone - An analogue of anthracycline anticancer drugs, interacts with DNA and induces apoptosis in human MDA-MB-231 breast adinocarcinoma cells: Evaluation of structure-activity relationship using computational, spectrUltrafast Electron Transfer in Complexes of Doxorubicin with Human Telomeric G-Quadruplexes and GC Duplexes Probed by Femtosecond Fluorescence Spectroscopy.New doxorubicin nanocarriers based on cyclodextrins.THE ROLE OF PROTEIN CHAPERONES IN THE SURVIVAL FROM ANTHRACYCLINE-INDUCED OXIDATIVE STRESS IN SACCHAROMYCES CEREVISIAE.
P2860
Q33356241-C90CEB99-C6F2-4ABA-9DF7-D8D62FD31AF1Q33618312-95DD2D7D-2FAA-47F8-9730-FE16AC072E95Q34557741-5FD7EF5D-2200-4C43-8197-0FB975DE7F8AQ38334464-B0743501-BEB1-4318-9517-40ED31E9097CQ38339597-9031F0D6-07C4-453F-B69A-0E8AACBF11F1Q39117681-A7DED16C-81E8-49A7-9D6C-5E87F88CA5BAQ39436550-AF53BE86-417B-4A01-BA46-D029C9BC4A13Q39496058-BC197AFE-D9FC-4158-BEBB-148787AD94EDQ39510887-E88AB55F-AA3E-4713-A96E-FBE6609C74DAQ43807501-3EB495F9-9CE4-44C2-BC23-49085CB29DBEQ46045314-52DCA403-D1B8-45E3-9209-69239205DF2CQ46530546-4F3EEE44-F106-4AFA-85EC-64E30356CD1FQ48258207-08B5E823-EAF1-4724-A7B3-DE6CFFE471F7Q51071180-2B3DA794-444A-4BE2-9C1B-FA671D0850A3Q52587039-121EFCBC-00C7-45FA-87A8-9ECBF31F5726
P2860
DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
DNA topoisomerase II structure ...... nto ternary complex formation.
@en
type
label
DNA topoisomerase II structure ...... nto ternary complex formation.
@en
prefLabel
DNA topoisomerase II structure ...... nto ternary complex formation.
@en
P50
P1476
DNA topoisomerase II structure ...... into ternary complex formation
@en
P2093
P304
P356
10.2174/138161207781757105
P577
2007-01-01T00:00:00Z